What is a stock summary page? Click here for an overview.
Business Description
Ascelia Pharma AB
ISIN : SE0010573113
Compare
Compare
Traded in other countries / regions
ACE.Sweden7ZA.GermanyACEs.UK IPO Date
2020-12-10Description
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway The company has two drug candidates Orviglance and Oncoral in clinical development.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.96 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 23.3 | |||||
| 3-Year EPS without NRI Growth Rate | 17.6 | |||||
| 3-Year FCF Growth Rate | 21.9 | |||||
| 3-Year Book Growth Rate | -49.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.15 | |||||
| 9-Day RSI | 43.15 | |||||
| 14-Day RSI | 45.36 | |||||
| 3-1 Month Momentum % | 47.9 | |||||
| 6-1 Month Momentum % | 53.72 | |||||
| 12-1 Month Momentum % | -48.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.35 | |||||
| Quick Ratio | 1.35 | |||||
| Cash Ratio | 1.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.5 | |||||
| Shareholder Yield % | -46.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -107.73 | |||||
| ROA % | -69.41 | |||||
| ROIC % | -84 | |||||
| 3-Year ROIIC % | 181.28 | |||||
| ROC (Joel Greenblatt) % | -11156.78 | |||||
| ROCE % | -73.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.55 | |||||
| Price-to-Tangible-Book | 9.84 | |||||
| EV-to-EBIT | -3.48 | |||||
| EV-to-Forward-EBIT | -3.27 | |||||
| EV-to-EBITDA | -3.48 | |||||
| EV-to-Forward-EBITDA | -3.27 | |||||
| EV-to-FCF | -3.66 | |||||
| Price-to-Net-Current-Asset-Value | 9.84 | |||||
| Price-to-Net-Cash | 19.68 | |||||
| Earnings Yield (Greenblatt) % | -28.74 | |||||
| FCF Yield % | -22.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ascelia Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.116 | ||
| Beta | 0.82 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.55 | ||
| Volatility % | 145.4 | ||
| 14-Day RSI | 45.36 | ||
| 14-Day ATR (€) | 0.036847 | ||
| 20-Day SMA (€) | 0.24142 | ||
| 12-1 Month Momentum % | -48.42 | ||
| 52-Week Range (€) | 0.111 - 0.852379 | ||
| Shares Outstanding (Mil) | 96.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ascelia Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ascelia Pharma AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ascelia Pharma AB Frequently Asked Questions
What is Ascelia Pharma AB(FRA:7ZA)'s stock price today?
The current price of FRA:7ZA is €0.20. The 52 week high of FRA:7ZA is €0.85 and 52 week low is €0.11.
When is next earnings date of Ascelia Pharma AB(FRA:7ZA)?
The next earnings date of Ascelia Pharma AB(FRA:7ZA) is 2025-05-16.
Does Ascelia Pharma AB(FRA:7ZA) pay dividends? If so, how much?
Ascelia Pharma AB(FRA:7ZA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers